Roland Schrmann - Bachem Holding Chief Officer

BANB Stock  CHF 67.40  1.65  2.39%   

Insider

Roland Schrmann is Chief Officer of Bachem Holding AG
Age 59
Phone41 58 595 2021
Webhttps://www.bachem.com

Bachem Holding Management Efficiency

The company has return on total asset (ROA) of 0.073 % which means that it generated a profit of $0.073 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1228 %, meaning that it generated $0.1228 on every $100 dollars invested by stockholders. Bachem Holding's management efficiency ratios could be used to measure how well Bachem Holding manages its routine affairs as well as how well it operates its assets and liabilities.
Bachem Holding AG has accumulated 499 K in total debt with debt to equity ratio (D/E) of 0.3, which may suggest the company is not taking enough advantage from borrowing. Bachem Holding AG has a current ratio of 1.5, which is within standard range for the sector. Debt can assist Bachem Holding until it has trouble settling it off, either with new capital or with free cash flow. So, Bachem Holding's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bachem Holding AG sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bachem to invest in growth at high rates of return. When we think about Bachem Holding's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Adesh KaulBasilea Pharmaceutica AG
49
Peer SchroderBasilea Pharmaceutica AG
N/A
Roberto GalliNewron Pharmaceuticals SpA
N/A
Ngo NhanCOSMO Pharmaceuticals SA
44
Alessandro LLMCOSMO Pharmaceuticals SA
60
Gerrit HauckBasilea Pharmaceutica AG
59
Gerhard LobmaierEvolva Holding SA
54
Niall DonnellyCOSMO Pharmaceuticals SA
51
Carsten DaweritzEvolva Holding SA
50
Dario EklundSanthera Pharmaceuticals Holdin
55
Marc SchraderSanthera Pharmaceuticals Holdin
N/A
Neville MDSanthera Pharmaceuticals Holdin
N/A
Laurenz KellenbergerBasilea Pharmaceutica AG
56
Oliver StrubSanthera Pharmaceuticals Holdin
60
Fabienne GschwindEvolva Holding SA
50
Philipp FrechEvolva Holding SA
N/A
Luigi LongoCOSMO Pharmaceuticals SA
44
Biagio ViganoCOSMO Pharmaceuticals SA
49
FCMA CGMASanthera Pharmaceuticals Holdin
60
Anne VosEvolva Holding SA
59
Davide MalavasiCOSMO Pharmaceuticals SA
50
Bachem Holding AG, a technology-based biochemicals company, provides services to the pharmaceutical and biotechnology industries primarily in Switzerland, the United States, Germany, Ireland, the United Kingdom, Austria, Japan, and internationally. Bachem Holding AG was founded in 1971 and is headquartered in Bubendorf, Switzerland. BACHEM N operates under Chemicals classification in Switzerland and is traded on Switzerland Exchange. It employs 1580 people. Bachem Holding AG (BANB) is traded on SIX Swiss Exchange in Switzerland and employs 1,663 people.

Management Performance

Bachem Holding AG Leadership Team

Elected by the shareholders, the Bachem Holding's board of directors comprises two types of representatives: Bachem Holding inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bachem. The board's role is to monitor Bachem Holding's management team and ensure that shareholders' interests are well served. Bachem Holding's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bachem Holding's outside directors are responsible for providing unbiased perspectives on the board's policies.
Thomas Fruh, Sec
Michael Suter, VP Accounting
Roland Schrmann, Chief Officer
Christian Sthelin, Director HR
Gunther Loidl, Chief Officer
JeanMarc Fellay, VP HR
Thomas Meier, Chief Officer
Michael Staroverov, Group Officer
Alain Schaffter, Chief Officer
Torsten Whr, Chief Officer

Bachem Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Bachem Holding a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Bachem Stock Analysis

When running Bachem Holding's price analysis, check to measure Bachem Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bachem Holding is operating at the current time. Most of Bachem Holding's value examination focuses on studying past and present price action to predict the probability of Bachem Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bachem Holding's price. Additionally, you may evaluate how the addition of Bachem Holding to your portfolios can decrease your overall portfolio volatility.